Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Ilian Iliev, CEO, NetScientific
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
NetScientific eyes opportunities after securing new capital
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Vivartia Group's Expansion Strategy and Market Dominance in Greece's Agri-Food Sector Part-1 | Athanasios Papanikolaou, CEO, Marfin Investment Group.
00:00:00
Fahar Merchant, PhD PRESIDENT AND CHIEF EXECUTIVE OFFICER, Medicenna Therapeutics Corp
00:10:00
Navigating the Future of Financial Planning with Dr. Martin Seay, Ph.D., CFP®
00:10:00
Good global citizenship takes on a distinct meaning in light of its many pro bono efforts|David I. Gottlieb,Partner,Cleary Gottlieb Steen & Hamilton LLP
00:10:00
focused on investing in technology startups operating in highly-regulated markets|Bradley Tusk, Managing Partner,Tusk Venture Partners
00:10:00
EY Chairman Carmine Di Sibio Discusses Hiring Trends, AI Impact, and European Market Strength | Carmine Di Sibio, Chairman, Ernst & Young.
00:10:00
Revolutionizing Biotechnology: The Impact of Directed Evolution Technology on Protein Skins
00:10:00
Conservatism and Classical Music: Matthew Continetti's Insights|Alexander Boot,Professor,School of Transnational Governance
00:10:00
Discovering the Future of Private Credit Markets: Insights from Eric Hirsch |Robert F. Smith, Chairman and CEO, Vista Equity Partner.
00:10:00
Barksdale Resources: Unveiling Promising Base Metal Exploration at One-to-One Mining Conference in New York
00:10:00
ENAV Soars with Strong Financials and Strategic Plan - CEO Pasqualino Monti Interviewed | Pasqualino Monti - CEO of ENAV
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.